Yu Waye Chu

Director Técnico/Científico/I+D en CYTOMX THERAPEUTICS, INC. .

Fortuna: 586 416 $ al 30/04/2024

56 años

Health Technology

Consumer Services

Cargos activos de Yu Waye Chu

Empresas	Cargo	Inicio	Fin
CYTOMX THERAPEUTICS, INC.	Director Técnico/Científico/I+D	17/07/2023	-

Empresas	Cargo	Inicio	Fin
FATE THERAPEUTICS, INC.	Director Técnico/Científico/I+D	18/04/2019	14/07/2023
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	01/01/2009	01/04/2019

Princeton University	Undergraduate Degree
University of Rochester School of Medicine & Dentistry	Doctorate Degree

Internacional

Estados Unidos

Operativa

Sectorial

Health Technology	4
Consumer Services	3

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	2
FATE THERAPEUTICS, INC.	Health Technology
CYTOMX THERAPEUTICS, INC.	Health Technology

Empresas privadas	1
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology

Empresas privadas

Health Technology